Spatial regulation of ARAF controls the MST2-Hippo pathway

References

• Matallanas D, Birtwistle M, Romano D, Zebisch A, Rauch J, von Kriegsheim A, Kolch W. Raf family kinases: old dogs have learned new tricks. Genes Cancer 2011; 2:232-60; PMID:21779496; http://dx.doi.org/10.1177/1947601911407323
   PubMedGoogle Scholar
• Yoon S, Seger R. The extracellular signal-regulated kinase: multiple substrates regulate diverse cellular functions. Growth Factors 2006; 24:21-44; PMID:16393692; http://dx.doi.org/10.1080/02699050500284218
   PubMed Web of Science ®Google Scholar
• Marais R, Light Y, Paterson HF, Mason CS, Marshall CJ. Differential regulation of Raf-1, A-Raf, and B-Raf by oncogenic ras and tyrosine kinases. J Biol Chem 1997; 272:4378-83; PMID:9020159; http://dx.doi.org/10.1074/jbc.272.7.4378
   PubMed Web of Science ®Google Scholar
• Forbes SA, Beare D, Gunasekaran P, Leung K, Bindal N, Boutselakis H, Ding M, Bamford S, Cole C, Ward S. COSMIC: exploring the world's knowledge of somatic mutations in human cancer. Nucleic acids Res 2015; 43:D805-11; PMID:25355519; http://dx.doi.org/10.1093/nar/gku1075
   PubMed Web of Science ®Google Scholar
• Lavoie H, Therrien M. Regulation of RAF protein kinases in ERK signalling. Nat Rev Mol Cell Biol 2015; 16:281-98; PMID:25907612; http://dx.doi.org/10.1038/nrm3979
   PubMed Web of Science ®Google Scholar
• Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, Teague J, Woffendin H, Garnett MJ, Bottomley W, et al. Mutations of the BRAF gene in human cancer. Nature 2002; 417:949-54; PMID:12068308; http://dx.doi.org/10.1038/nature00766
   PubMed Web of Science ®Google Scholar
• Cancer Genome Atlas N. Genomic Classification of Cutaneous Melanoma. Cell 2015; 161:1681-96; PMID:26091043; http://dx.doi.org/10.1016/j.cell.2015.05.044
   PubMed Web of Science ®Google Scholar
• Cancer Genome Atlas Research N. Integrated genomic characterization of papillary thyroid carcinoma. Cell 2014; 159:676-90; PMID:25417114; http://dx.doi.org/10.1016/j.cell.2014.09.050
   PubMed Web of Science ®Google Scholar
• Hu J, Stites EC, Yu H, Germino EA, Meharena HS, Stork PJS, Kornev AP, Taylor SS, Shaw AS. Allosteric Activation of Functionally Asymmetric RAF Kinase Dimers. Cell 2013; 154:1036-46; PMID:23993095; http://dx.doi.org/10.1016/j.cell.2013.07.046
   PubMed Web of Science ®Google Scholar
• Baljuls A, Kholodenko BN, Kolch W. It takes two to tango–signalling by dimeric Raf kinases. Mol Biosyst 2013; 9:551-8; PMID:23212737; http://dx.doi.org/10.1039/C2MB25393C
   PubMed Web of Science ®Google Scholar
• Kholodenko B, Hancock J, Kolch W. Signalling ballet in space and time. Nat Rev Mol Cell Biol 2010; 11:414-26; PMID:20495582; http://dx.doi.org/10.1038/nrm2901
   PubMed Web of Science ®Google Scholar
• Kolch W. Coordinating ERK/MAPK signalling through scaffolds and inhibitors. Nat Rev Mol Cell Biol 2005; 6:827-37; PMID:16227978; http://dx.doi.org/10.1038/nrm1743
   PubMed Web of Science ®Google Scholar
• Costanzo-Garvey DL, Pfluger PT, Dougherty MK, Stock JL, Boehm M, Chaika O, Fernandez MR, Fisher K, Kortum RL, Hong EG, et al. KSR2 is an essential regulator of AMP kinase, energy expenditure, and insulin sensitivity. Cell Metab 2009; 10:366-78; PMID:19883615; http://dx.doi.org/10.1016/j.cmet.2009.09.010
   PubMed Web of Science ®Google Scholar
• Fabian JR, Daar IO, Morrison DK. Critical tyrosine residues regulate the enzymatic and biological activity of Raf-1 kinase. Mol Cell Biol 1993; 13:7170-9; PMID:7692235; http://dx.doi.org/10.1128/MCB.13.11.7170
   PubMed Web of Science ®Google Scholar
• Marais R, Light Y, Paterson HF, Marshall CJ. Ras recruits Raf-1 to the plasma membrane for activation by tyrosine phosphorylation. Embo J 1995; 14:3136-45. PMID:7542586.
   PubMed Web of Science ®Google Scholar
• Baljuls A, Mueller T, Drexler HC, Hekman M, Rapp UR. Unique N-region determines low basal activity and limited inducibility of A-RAF kinase: the role of N-region in the evolutionary divergence of RAF kinase function in vertebrates. J Biol Chem 2007; 282:26575-90; PMID:17613527; http://dx.doi.org/10.1074/jbc.M702429200
   PubMed Web of Science ®Google Scholar
• Rebocho AP, Marais R. ARAF acts as a scaffold to stabilize BRAF:CRAF heterodimers. Oncogene 2013; 32:3207-12; PMID:22926515; http://dx.doi.org/10.1038/onc.2012.330
   PubMed Web of Science ®Google Scholar
• Mooz J, Oberoi-Khanuja TK, Harms GS, Wang W, Jaiswal BS, Seshagiri S, Tikkanen R, Rajalingam K. Dimerization of the kinase ARAF promotes MAPK pathway activation and cell migration. Sci Signal 2014; 7:ra73; PMID:25097033; http://dx.doi.org/10.1126/scisignal.2005484
   PubMed Web of Science ®Google Scholar
• Rauch J, O'Neill E, Mack B, Matthias C, Munz M, Kolch W, Gires O. Heterogeneous nuclear ribonucleoprotein H blocks MST2-mediated apoptosis in cancer cells by regulating A-Raf transcription. Cancer Res 2010; 70:1679-88; PMID:20145135; http://dx.doi.org/10.1158/0008-5472.CAN-09-2740
   PubMed Web of Science ®Google Scholar
• O'Neill E, Rushworth L, Baccarini M, Kolch W. Role of the kinase MST2 in suppression of apoptosis by the proto-oncogene product Raf-1. Science 2004; 306:2267-70; PMID:15618521; http://dx.doi.org/10.1126/science.1103233
   PubMed Web of Science ®Google Scholar
• Romano D, Nguyen LK, Matallanas D, Halasz M, Doherty C, Kholodenko BN, Kolch W. Protein interaction switches coordinate Raf-1 and MST2/Hippo signalling. Nat Cell Biol 2014; 16:673-84; PMID:24929361; http://dx.doi.org/10.1038/ncb2986
   PubMed Web of Science ®Google Scholar
• Matallanas D, Romano D, Yee K, Meissl K, Kucerova L, Piazzolla D, Baccarini M, Vass JK, Kolch W, O'neill E. RASSF1A elicits apoptosis through an MST2 pathway directing proapoptotic transcription by the p73 tumor suppressor protein. Mol Cell 2007; 27:962-75; PMID:17889669; http://dx.doi.org/10.1016/j.molcel.2007.08.008
   PubMed Web of Science ®Google Scholar
• Rauch J, Moran-Jones K, Albrecht V, Schwarzl T, Hunter K, Gires O, Kolch W. c-Myc regulates RNA splicing of the A-Raf kinase and its activation of the ERK pathway. Cancer Res 2011; 71:4664-74; PMID:21512137; http://dx.doi.org/10.1158/0008-5472.CAN-10-4447
   PubMed Web of Science ®Google Scholar
• Shilo A, Ben Hur V, Denichenko P, Stein I, Pikarsky E, Rauch J, Kolch W, Zender L, Karni R. Splicing factor hnRNP A2 activates the Ras-MAPK-ERK pathway by controlling A-Raf splicing in hepatocellular carcinoma development. RNA 2014; 20:505-15; PMID:24572810; http://dx.doi.org/10.1261/rna.042259.113
   PubMed Web of Science ®Google Scholar
• Yuryev A, Ono M, Goff SA, Macaluso F, Wennogle LP. Isoform-specific localization of A-RAF in mitochondria. Mol Cell Biol 2000; 20:4870-8; PMID:10848612; http://dx.doi.org/10.1128/MCB.20.13.4870-4878.2000
   PubMed Web of Science ®Google Scholar
• Rauch J, Vandamme D, Mack B, McCann B, Volinsky N, Blanco A, Gires O, Kolch W. Differential localization of A-Raf regulates MST2-mediated apoptosis during epithelial differentiation. Cell Death Differ 2016; 23:1283-95; PMID:26891695; http://dx.doi.org/10.1038/cdd.2016.2
   PubMed Web of Science ®Google Scholar
• Baljuls A, Schmitz W, Mueller T, Zahedi RP, Sickmann A, Hekman M, Rapp UR. Positive regulation of A-RAF by phosphorylation of isoform-specific hinge segment and identification of novel phosphorylation sites. J Biol Chem 2008; 283:27239-54; PMID:18662992; http://dx.doi.org/10.1074/jbc.M801782200
   PubMed Web of Science ®Google Scholar
• Farrell J, Kelly C, Rauch J, Kida K, Garcia-Munoz A, Monsefi N, Turriziani B, Doherty C, Mehta JP, Matallanas D, et al. HGF induces epithelial-to-mesenchymal transition by modulating the mammalian hippo/MST2 and ISG15 pathways. J Proteome Res 2014; 13:2874-86; PMID:24766643; http://dx.doi.org/10.1021/pr5000285
   PubMed Web of Science ®Google Scholar
• Zmuidzinas A, Gould GW, Yager JD. Expression of c-raf-1 and A-raf-1 during differentiation of 3T3-L1 preadipocyte fibroblasts into adipocytes. Biochem Biophys Res Commun 1989; 162:1180-7; PMID:2669746; http://dx.doi.org/10.1016/0006-291X(89)90798-5
   PubMed Web of Science ®Google Scholar
• Yokoyama T, Takano K, Yoshida A, Katada F, Sun P, Takenawa T, Andoh T, Endo T. DA-Raf1, a competent intrinsic dominant-negative antagonist of the Ras-ERK pathway, is required for myogenic differentiation. J Cell Biol 2007; 177:781-93; PMID:17535970; http://dx.doi.org/10.1083/jcb.200703195
   PubMed Web of Science ®Google Scholar
• Gomez M, Gomez V, Hergovich A. The Hippo pathway in disease and therapy: cancer and beyond. Clin Transl Med 2014; 3:22; PMID:25097725; http://dx.doi.org/10.1186/2001-1326-3-22
   PubMedGoogle Scholar
• Yu FX, Guan KL. The Hippo pathway: regulators and regulations. Genes Dev 2013; 27:355-71; PMID:23431053; http://dx.doi.org/10.1101/gad.210773.112
   PubMed Web of Science ®Google Scholar
• Harvey KF, Zhang X, Thomas DM. The Hippo pathway and human cancer. Nat Rev Cancer 2013; 13:246-57; PMID:23467301; http://dx.doi.org/10.1038/nrc3458
   PubMed Web of Science ®Google Scholar
• Bernascone I, Martin-Belmonte F. Crossroads of Wnt and Hippo in epithelial tissues. Trends in cell biology 2013; 23:380-9; PMID:23607968; http://dx.doi.org/10.1016/j.tcb.2013.03.007
   PubMed Web of Science ®Google Scholar
• Li P, Chen Y, Mak KK, Wong CK, Wang CC, Yuan P. Functional role of Mst1/Mst2 in embryonic stem cell differentiation. PloS one 2013; 8:e79867; PMID:24224013; http://dx.doi.org/10.1371/journal.pone.0079867
   PubMed Web of Science ®Google Scholar
• Du X, Dong Y, Shi H, Li J, Kong S, Shi D, Sun LV, Xu T, Deng K, Tao W. Mst1 and mst2 are essential regulators of trophoblast differentiation and placenta morphogenesis. PloS one 2014; 9:e90701; PMID:24595170; http://dx.doi.org/10.1371/journal.pone.0090701
   PubMed Web of Science ®Google Scholar
• Gao T, Zhou D, Yang C, Singh T, Penzo-Mendez A, Maddipati R, Tzatsos A, Bardeesy N, Avruch J, Stanger BZ. Hippo signaling regulates differentiation and maintenance in the exocrine pancreas. Gastroenterology 2013; 144:1543-53, 53 e1.
   PubMed Web of Science ®Google Scholar
• Graves JD, Gotoh Y, Draves KE, Ambrose D, Han DK, Wright M, Chernoff J, Clark EA, Krebs EG. Caspase-mediated activation and induction of apoptosis by the mammalian Ste20-like kinase Mst1. EMBO J 1998; 17:2224-34; PMID:9545236; http://dx.doi.org/10.1093/emboj/17.8.2224
   PubMed Web of Science ®Google Scholar
• Wang X, Wang T-T, White JH, Studzinski GP. Expression of human kinase suppressor of Ras 2 (hKSR-2) gene in HL60 leukemia cells is directly upregulated by 1,25-dihydroxyvitamin D(3) and is required for optimal cell differentiation. Exp Cell Res 2007; 313:3034-45; PMID:17599832; http://dx.doi.org/10.1016/j.yexcr.2007.05.021
   PubMed Web of Science ®Google Scholar
• Wang Y, Li Z, Xu P, Huang L, Tong J, Huang H, Meng A. Angiomotin-like2 gene (amotl2) is required for migration and proliferation of endothelial cells during angiogenesis. J Biol Chem 2011; 286:41095-104; PMID:21937427; http://dx.doi.org/10.1074/jbc.M111.296806
   PubMed Web of Science ®Google Scholar
• Zhao B, Li L, Lu Q, Wang LH, Liu CY, Lei Q, Guan KL. Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein. Genes Dev 2011; 25:51-63; PMID:21205866; http://dx.doi.org/10.1101/gad.2000111
   PubMed Web of Science ®Google Scholar
• McCall CA, Cohen JJ. Programmed cell death in terminally differentiating keratinocytes: role of endogenous endonuclease. J Investigative Dermatol 1991; 97:111-4; PMID:1647418; http://dx.doi.org/10.1111/1523-1747.ep12478519
   PubMed Web of Science ®Google Scholar
• Weil M, Raff MC, Braga VM. Caspase activation in the terminal differentiation of human epidermal keratinocytes. Curr Biol 1999; 9:361-4; PMID:10209121; http://dx.doi.org/10.1016/S0960-9822(99)80162-6
   PubMed Web of Science ®Google Scholar
• Lu QL, Abel P, Foster CS, Lalani EN. bcl-2: role in epithelial differentiation and oncogenesis. Human pathology 1996; 27:102-10; PMID:8617450; http://dx.doi.org/10.1016/S0046-8177(96)90362-7
   PubMed Web of Science ®Google Scholar
• Kholodenko BN, Birtwistle MR. Four-dimensional dynamics of MAPK information processing systems. Wiley Interdiscip Rev Syst Biol Med 2009; 1:28-44; PMID:20182652; http://dx.doi.org/10.1002/wsbm.16
   PubMed Web of Science ®Google Scholar
• Witzel F, Maddison L, Bluthgen N. How scaffolds shape MAPK signaling: what we know and opportunities for systems approaches. Front Physiol 2012; 3:475; PMID:23267331; http://dx.doi.org/10.3389/fphys.2012.00475
   PubMed Web of Science ®Google Scholar
• Liu L, Channavajhala PL, Rao VR, Moutsatsos I, Wu L, Zhang Y, Lin LL, Qiu Y. Proteomic characterization of the dynamic KSR-2 interactome, a signaling scaffold complex in MAPK pathway. Biochim Biophys Acta 2009; 1794:1485-95; PMID:19563921; http://dx.doi.org/10.1016/j.bbapap.2009.06.016
   PubMed Web of Science ®Google Scholar
• Le Mellay V, Houben R, Troppmair J, Hagemann C, Mazurek S, Frey U, Beigel J, Weber C, Benz R, Eigenbrodt E, et al. Regulation of glycolysis by Raf protein serine/threonine kinases. Adv Enzyme Regul 2002; 42:317-32; PMID:12123723; http://dx.doi.org/10.1016/S0065-2571(01)00036-X
   PubMedGoogle Scholar